Xact Kapitalforvaltning’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$328K Hold
5,723
0.01% 954
2019
Q4
$640K Hold
5,723
0.01% 832
2019
Q3
$550K Hold
5,723
0.01% 864
2019
Q2
$490K Hold
5,723
0.01% 935
2019
Q1
$476K Hold
5,723
0.01% 950
2018
Q4
$367K Hold
5,723
0.01% 1104
2018
Q3
$453K Hold
5,723
0.01% 1039
2018
Q2
$419K Hold
5,723
0.01% 1076
2018
Q1
$362K Buy
5,723
+600
+12% +$35.8K 0.01% 1061
2017
Q4
$261K Buy
+5,123
New +$267K 0.01% 1042

Other funds holding CNMD

Xact Kapitalforvaltning's CNMD Position: Q1 2020 in Review

Xact Kapitalforvaltning held its CONMED (CNMD) position steady in Q1 2020 at 5,723 shares worth $328K. The position accounts for 0.01% of the portfolio, ranked #954.

Xact Kapitalforvaltning first reported a position in CNMD in Q4 2017 and has held it in 10 quarters since. The position peaked at $640K in Q4 2019. 229 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

  • Xact Kapitalforvaltning held 5,723 shares of CONMED worth $328K as of Q1 2020.
  • Xact Kapitalforvaltning left its CONMED share count unchanged in Q1 2020.
  • CONMED made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #954 holding.
  • Xact Kapitalforvaltning first reported a position in CONMED in Q4 2017 and has held it in 10 quarters since.
  • Xact Kapitalforvaltning's CONMED position peaked at $640K in Q4 2019.
  • 229 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.